Wednesday, June 10, 2026

pharma

Ablynx NV

Ablynx NV patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
0
Drugs
0
Patents
25
Intelligence · Patents

Ablynx NV patents

25 pharmaceutical patents indexed for Ablynx NV. 0 expire within 24 months.

Ablynx NV has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2026078159

    AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT

    Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. WO 2026030375

    NANOPARTICULES LIPIDIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

    Expires Wed Jan 31 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2025262150

    MOLÉCULES DE RECRUTEMENT D'ANTICORPS

    Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. AR 133055

    DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA DIRIGIDOS A PD-L1

    Expires Tue Aug 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. MX 2025007399

    PROTEIN-BASED CONJUGATION CARRIERS

    Expires Thu Jul 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. WO 2025133166

    VÉHICULES À BASE DE PROTÉINES POUR CONJUGAISON D'AMINE SPÉCIFIQUE À UN SITE

    Expires Wed Jun 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. WO 2025133253

    EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE

    Expires Wed Jun 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. WO 2025133252

    DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT CEACAM5

    Expires Wed Jun 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. WO 2025114529

    ANTICORPS MULTISPÉCIFIQUES RECONNAISSANT L'ALBUMINE SÉRIQUE HUMAINE, TCR ET FRACTION RECONNAISSANT L'ANTIGÈNE TUMORAL

    Expires Wed May 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 2025129145

    BI- AND MULTIVALENT ALBUMIN BINDERS

    Expires Wed Apr 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 2025034260

    FCRN ANTAGONISTS FOR TREATMENT OF IGG-RELATED DISEASES AND DISORDERS

    Expires Wed Jan 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. WO 2024261235

    PROTÉINES CHIMÉRIQUES POUR MODULER L'ACTIVITÉ D'UN RÉCEPTEUR DE CYTOKINE

    Expires Wed Dec 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 2024368250

    POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR

    Expires Wed Nov 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. NZ 743471

    Improved immunoglobulin variable domains

    Expires Thu Jul 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. WO 2024133935

    EXCIPIENTS DE CONJUGAISON PROTÉIQUES

    Expires Wed Jun 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 2024166750

    GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION

    Expires Wed May 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. EP 4350345

    VERFAHREN ZUR VORHERSAGE, ERKENNUNG UND REDUZIERUNG VON ASPEZIFISCHER PROTEININTERFERENZ IN TESTS MIT VARIABLEN IMMUNGLOBULIN-EINZELDOMÄNEN

    Expires Tue Apr 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. CA 3263005

    POLYPEPTIDES SE LIANT À UN ÉPITOPE SPÉCIFIQUE DU RÉCEPTEUR FC NÉONATAL

    Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. CA 3262048

    CX3CR1-BINDING COMPOUNDS, METHODS AND USES THEREOF

    Expires Wed Jan 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. CA 3259417

    DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT LE RÉCEPTEUR DES LYMPHOCYTES T

    Expires Wed Dec 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. CN 116783219

    T cell recruitment polypeptides based on TCR alpha/beta reactivity

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. CA 3242445

    POLYPEPTIDES COMPRENANT DES DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT TCRAS, CD33 ET CD123

    Expires Wed Jun 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. AR 124446

    POLIPÉPTIDOS RECLUTADORES DE CÉLULAS T BASADOS EN LA REACTIVIDAD DE TCR a / b

    Expires Tue Mar 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. AR 124426

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA QUE SE DIRIGEN A IL-6 Y TNF-a

    Expires Tue Mar 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. AR 124425

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES SIMPLES DE INMUNOGLOBULINA DIRIGIDOS A GLYPICAN-3 Y AL RECEPTOR DE CÉLULAS T

    Expires Tue Mar 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Ablynx NV have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Ablynx NV patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.